(Total Views: 232)
Posted On: 01/16/2020 3:29:40 PM
Post# of 112
NetworkNewsBreaks – MCTC Holdings, Inc. (MCTC) Launches Project Varin to Develop New Delivery Systems for THC-V
MCTC Holdings (OTC: MCTC), a cannabinoid science forward company developing unique infusion technologies and cannabinoid delivery systems, today announced Project Varin, a program to develop new delivery systems for Tetrahydrocannabivarin (“THC-V”). According to the update, THC-V is becoming known within the cannabinoid sciences arena as the “Skinny Cannabinoid” due to its purported appetite suppression qualities and potential use as a treatment against obesity-associated glucose intolerance. “THC-V is so rare and difficult to obtain, it is currently valued at around $500,000 per kilogram, which is approximately ten times the price of gold. In order for the marketplace to utilize this potentially beneficial exotic cannabinoid, new delivery systems will need to be developed to allow the amount of THC-V administered to be efficiently utilized by the human body,” MCTC Holdings CEO Arman Tabatabaei said in the news release. “This issue of bioavailability has been a significant ongoing concern for the industry relative to many cannabinoids, but with the rarity of THC-V, the need for efficient delivery is hugely amplified. It is our goal to solve this pressing industry issue. Based on our already completed laboratory accomplishments and our patent-pending technologies, we believe this goal is within our reach.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
MCTC Holdings (OTC: MCTC), a cannabinoid science forward company developing unique infusion technologies and cannabinoid delivery systems, today announced Project Varin, a program to develop new delivery systems for Tetrahydrocannabivarin (“THC-V”). According to the update, THC-V is becoming known within the cannabinoid sciences arena as the “Skinny Cannabinoid” due to its purported appetite suppression qualities and potential use as a treatment against obesity-associated glucose intolerance. “THC-V is so rare and difficult to obtain, it is currently valued at around $500,000 per kilogram, which is approximately ten times the price of gold. In order for the marketplace to utilize this potentially beneficial exotic cannabinoid, new delivery systems will need to be developed to allow the amount of THC-V administered to be efficiently utilized by the human body,” MCTC Holdings CEO Arman Tabatabaei said in the news release. “This issue of bioavailability has been a significant ongoing concern for the industry relative to many cannabinoids, but with the rarity of THC-V, the need for efficient delivery is hugely amplified. It is our goal to solve this pressing industry issue. Based on our already completed laboratory accomplishments and our patent-pending technologies, we believe this goal is within our reach.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
